ArticleThoracic cancer2022

TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma.

Yue Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.